Kaminari Medical's recent €3.8M funding will accelerate the development of their innovative imaging platform, aimed at transforming cardiovascular diagnostics and therapy guidance.
Jeroen Kodde, CEO, emphasizes the importance of quickly advancing their technology to healthcare providers to improve outcomes for patients affected by cardiovascular disease.
Professor Ton van der Steen highlights that the investment will facilitate bringing scientific advancements directly to patients, showcasing a successful model of knowledge valorisation.
As coronary artery disease remains a leading cause of death, the need for precise diagnostics tools to identify risky plaques is critical for effective treatment.
Collection
[
|
...
]